Straus, D. J., Johnson, J. L., LaCasce, A. S., Bartlett, N. L., Kostakoglu, L., Hsi, E. D., . . . Cheson, B. D. (2011). Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: Pretreatment prognostic factors and interim PET. American Society of Hematology.
Chicago Style citaatStraus, David J., et al. Doxorubicin, Vinblastine, and Gemcitabine (CALGB 50203) for Stage I/II Nonbulky Hodgkin Lymphoma: Pretreatment Prognostic Factors and Interim PET. American Society of Hematology, 2011.
MLA citatieStraus, David J., et al. Doxorubicin, Vinblastine, and Gemcitabine (CALGB 50203) for Stage I/II Nonbulky Hodgkin Lymphoma: Pretreatment Prognostic Factors and Interim PET. American Society of Hematology, 2011.